Tonghua Golden-Horse Pharmaceutical Reports 92.1% Drop in Net Profit for First Three Quarters

Stock News10-26 16:28

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (000766.SZ) has released its third-quarter report for 2026.

For the first three quarters, the company achieved operating revenue of 737 million yuan, representing a year-on-year decline of 17.45%.

Net profit attributable to shareholders of the listed company stood at 1.9722 million yuan, down 92.10% compared with the same period last year.

Net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 2.1272 million yuan.

Basic earnings per share came in at 0.002 yuan.

The change in the company's performance was mainly attributable to a decline in sales revenue during the period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment